CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-28 | KHOSLA CHAITAN PHD Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-05-28 | Giraudo Bryan Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2020-04-29 | PATEL DINESH V PH D President and CEO | Gift | −2,000 | 437,990 | ||
| 2020-03-20 | PATEL DINESH V PH D President and CEO | Option exercise | +10,000 | $1.89 | $19K | 439,990 |
| 2020-03-20 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −10,000 | 34,087 | ||
| 2020-03-12 | PATEL DINESH V PH D President and CEO | Option exercise | +18,344 | $1.16 | $21K | 429,990 |
| 2020-03-12 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −18,344 | 0 | ||
| 2020-03-12 | SELICK HAROLD E Director | Purchase | +12,000 | $6.70 | $80K | 15,310 |
| 2020-02-28 | Saks Samuel R Chief Medical Officer | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2020-02-28 | PATEL DINESH V PH D President and CEO | Grant or award · Stock Option (right to buy) | +235,000 | 235,000 | ||
| 2020-02-28 | Liu David Y Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2020-02-28 | Kalkofen Donald A. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2020-02-28 | Gupta Suneel Chief Development Officer | Grant or award · Stock Option (right to buy) | +85,000 | 85,000 | ||
| 2019-12-03 | Giraudo Bryan Director | Purchase | +8,000 | $5.70 | $46K | 8,000 |
| 2019-12-03 | Gupta Suneel EVP Clinical Operations | Purchase | +30,000 | $5.13 | $154K | 49,500 |
| 2019-12-03 | Kalkofen Donald A. Chief Financial Officer | Purchase | +613 | $5.10 | $3K | 613 |
| 2019-12-03 | Kalkofen Donald A. Chief Financial Officer | Purchase | +562 | $5.09 | $3K | 1,175 |
| 2019-12-03 | PATEL DINESH V PH D President and CEO | Purchase | +10,000 | $5.55 | $56K | 389,824 |
| 2019-12-03 | PATEL DINESH V PH D President and CEO | Purchase | +20,000 | $5.65 | $113K | 409,824 |
| 2019-11-26 | PATEL DINESH V PH D President and CEO | Option exercise | +4,000 | $1.16 | $5K | 379,824 |
Page 20 of 29 · 580 trades